Low prevalence of subclinical synovitis in patients with juvenile idiopathic arthritis (JIA) in long-term clinical remission on medication

被引:1
|
作者
Loredo, Claudia [1 ]
Yanez, Patricia [1 ]
Hernandez-Diaz, Cristina [2 ]
Cruz-Arenas, Esteban [3 ]
Ventura-Rios, Lucio [4 ]
机构
[1] Inst Mexicano Seguro Social IMSS, Ctr Med Nacl Siglo 21, Dept Pediat Rheumatol, Mexico City, Mexico
[2] Hosp Juarez Mexico, Rheumatol Serv, Mexico City, Mexico
[3] Hosp Epidemiol Surveillance Unit Sociomed Res, Inst Nacl RehabilLuis Guillermo Ibarra Ibarra, Mexico City, Mexico
[4] Inst Nacl RehabilLuis Guillermo Ibarra Ibarra, Div Rheumatol, Calzada Mex Xochimilco 289, Mexico City, Mexico
关键词
Clinically inactive disease; Juvenile idiopathic arthritis; Remission; Subclinical synovitis; Ultrasound; INACTIVE DISEASE; ULTRASOUND; STATE; ULTRASONOGRAPHY; RELIABILITY;
D O I
10.1007/s10067-023-06729-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subclinical synovitis is highly prevalent in patients with JIA in clinical remission (CR) with a short duration. The objective was to evaluate its prevalence by ultrasound (US) in patients with JIA in long CR during a one-year follow-up. In this prospective and longitudinal study, we included 76 patients with JIA according to ILAR with CR by the Wallace modified criteria and JADAS27 and compared them with 22 patients with active disease. Clinical and demographic characteristics were recorded. US evaluation was by 10-joint count. Differences in US evaluations were analyzed by the Mann-Whitney U test. There were no differences among the two group with regard to disease duration at enrollment, and age (p = 0.540 and p = 0.080, respectively), but JADAS 27, CHAQ, and acute phase reactants were significantly higher (p < 0.001) in the clinically active group. The prevalence of subclinical synovitis at baseline and the end of the study in the CR group was 18.4% and 11.8%, respectively, while it was 100% and 40.9% in the active disease group. Subclinical synovitis at baseline was significantly more prevalent in the clinically active group (elbow, p = 0.01; wrist, p = 0.001; MCP 2, p = 0.001; knee, p = 0.001 and ankle p = 0.001; and PD only in the ankle, p = 0.002). The concordance of inter-reader reliability in all evaluated joints was excellent (p = 0.001). Although the prevalence of subclinical synovitis is low in patients with JIA with long-term clinical remission on medication, a percentage of patients continue to have subclinical involvement that could predict the risk of relapse and structural damage.
引用
收藏
页码:393 / 398
页数:6
相关论文
共 50 条
  • [1] Low prevalence of subclinical synovitis in patients with juvenile idiopathic arthritis (JIA) in long-term clinical remission on medication
    Claudia Loredo
    Patricia Yañez
    Cristina Hernández-Díaz
    Esteban Cruz-Arenas
    Lucio Ventura-Ríos
    Clinical Rheumatology, 2024, 43 : 393 - 398
  • [2] Long-Term Safety of Etanercept in Patients with Juvenile Idiopathic Arthritis (JIA)
    Minden, Kirsten
    Niewerth, Martina
    Klotsche, Jens
    Hammer, Michael
    Haas, Johannes Peter
    Ganser, Gerd
    Horneff, Gerd
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S493 - S493
  • [3] Long-term safety of Etanercept in patients with juvenile idiopathic arthritis (JIA)
    Minden, K.
    Klotsche, J.
    Niewerth, M.
    Horneff, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 13 - 13
  • [4] SAFETY PROFILE OF ETANERCEPT IN LONG-TERM USE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Klotsche, Jens
    Klein, Ariane
    Niewerth, Martina
    Ganser, Gerd
    Aries, Peer
    Walther, Marisa
    Haas, Peter
    Keysser, Gernot
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 102 - 102
  • [5] Therapy Survival and Long-Term Safety of Etanercept in Patients with juvenile idiopathic Arthritis (JIA)
    Klotsche, J.
    Niewerth, M.
    Weber, K.
    Hammer, M.
    Haas, J.
    Horneff, G.
    Minden, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 92 - 93
  • [6] Subclinical synovitis detected by ultrasound in patients with oligoarticular JIA in clinical remission
    Molina, C.
    Santos, C.
    Modesto, C.
    Arnal, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 416 - 416
  • [7] DIABETES PREVALENCE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Schenck, S.
    Holl, R. W.
    Niewerth, M.
    Klotsche, J.
    Minden, K.
    Rosenbauer, J.
    Thon, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 108 - 108
  • [8] Preliminary Prospective Study Of Ultrasonography In Patients With Juvenile Idiopathic Arthritis In Clinical Remission: Subclinical Synovitis May Predict Flare?
    Miotto e Silva, Vanessa B.
    Mitraud, Sonia A. V.
    Furtado, Rita N. V.
    Natour, Jamil
    Terreri, Maria Teresa
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S125 - S126
  • [9] Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
    Klotsche, Jens
    Niewerth, Martina
    Haas, Johannes-Peter
    Huppertz, Hans-Iko
    Zink, Angela
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 855 - 861
  • [10] LONG-TERM SAFETY OF ETANERCEPT AND ADALIMUMAB COMPARED TO METHOTREXATE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Klotsche, J.
    Niewerth, M.
    Seipelt, E.
    Horneff, G.
    Minden, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 114 - 114